Pure Global
Disease / condition

Atopic Dermatitis clinical trials

Free access to 784 studies·10+ countries·Updated daily152 recruiting
784
Total trials
10+
Countries
10+
Sponsors
152
Recruiting
By phase
N/A292
Phase 2189
Phase 3114
Phase 173
Phase 468
By status
Completed400
Recruiting152
Not yet recruit...98
Terminated41
Unknown31
Top countries
United States of America176
China52
Germany32
Japan28
South Korea24
Top sponsors
LEO Pharma37
Eli Lilly and Comp...26
AbbVie19
Pfizer17
Amgen16
Recent trials
Latest clinical trials for Atopic Dermatitis
2018-000904-40
Long-Term Safety Of AN2728 Topical Ointment, 2% In The Treatment Of Children, Adolescents, And Adults (Ages 2 Years And Older) With Atopic Dermatitis
Pfizer Inc.
2015-001040-11
Proactive treatment with 0.03% tacrolimus cream in children with moderate/severe dermatitis
Astellas Pharma China, Inc.
2020-000875-20
Study to Assess Efficacy and Safety of Two Regimens of Crisaborole Ointment 2% in Japanese Participants Aged ≥ 2 Years with Mild to Moderate Atopic Dermatitis
Pfizer Inc.
2019-002836-10
A Study of Crisaborole ointment 2% in children aged 3-24 months with mild to moderate atopic dermatitis
Pfizer Inc.
2021-006538-38
A STUDY TO EVALUATE IF CRISABOROLE OINTMENT 2% WORKS WELL AND SAFE IN 2 YEARS AND OLDER CHINESE AND JAPANESE ECZEMA PATIENTS
Pfizer Inc.
2018-000731-27
Safety And Efficacy Of AN2728 Topical Ointment, 2% In Children, Adolescents, And Adults (Ages 2 Years And Older) With Atopic Dermatitis
Pfizer Inc.
2017-001765-25
An Investigation of the Safety and Efficacy of Elidel® 1% Cream in Atopic Disease Modification, Assessed in a 3-year Randomized Double-blind Vehicle Controlled Phase to Evaluate Effects on Atopic Dermatitis in Infants, and a 2-3 Year Openlabel Phase to Evaluate the Effect of Early Intervention Versus Delayed Intervention With Elidel® on the Incidence of Asthma in Children
Novartis
NCT06421740Not yet recr...
An Observational Study to Assess Real-World Use of Upadacitinib Tablets in Adolescent and Adult Participants With Moderate to Severe Atopic Dermatitis in China
AbbVie
NCT06415175Not yet recr...
Study in Paediatric Patients With Atopic Dermatitis Treated With Dupilumab in Spain
Sanofi
NCT06412094Completed
Use of a Mobile Health App in Managing Pediatric Atopic Dermatitis
Avanta Trading Ltd.Russian Federation
NCT06397911·Phase 2Not yet recr...
Evaluate Efficacy, Pharmacokinetics, and Safety of Repeat Subcutaneous Doses of FB825 in Adults With Moderate-to-Severe Atopic Dermatitis
Oneness Biotech Co., Ltd.
NCT06397781·Phase 4Not yet recr...
Effect of S. Aureus Skin Decolonization on Disease Severity in Atopic Dermatitis Patients
Boston Children's Hospital
NCT06395948·Phase 2Recruiting
A Study Evaluating APG777 in Atopic Dermatitis
Apogee Therapeutics, Inc.Canada,United States of America
NCT06389136·Phase 3Not yet recr...
A Study of Upadacitinib in Adult Participants With Moderate-to-Severe Atopic Dermatitis and Inadequate Response to Dupilumab
AbbVie
NCT06383468·Phase 3Recruiting
A Phase III Study to Evaluate the Efficacy and Safety of AK120 in Patients With Moderate to Severe Atopic Dermatitis
AkesoChina
NCT06363461·Phase 2Recruiting
Study of TDM-180935 in Atopic Dermatitis Patients
Technoderma Medicines Inc.United States of America
NCT06345404·Phase 1Recruiting
Safety, Tolerability, and Preliminary Efficacy of Soquelitinib in Participants With Moderate to Severe AD
Corvus Pharmaceuticals, Inc.United States of America
NCT06311682·Phase 3Not yet recr...
A Trial to Evaluate the Efficacy and Safety of Tralokinumab in Combination With Topical Corticosteroids in Children and Infants With Moderate-to-severe Atopic Dermatitis
LEO Pharma
NCT06366932·Phase 4Recruiting
Optimization of Atopic Dermatitis Treatment That Requires Second-line Systemic Therapy Through Predictive Models
Instituto de Investigación Hos...Spain
NCT06309355·Phase 2Not yet recr...
Topical YR001 Ointment in Adult With Mild to Moderate Atopic Dermatitis
Hangzhou Yirui Pharmaceutical ...United States of America
View all 784 trials →
About this record

Access comprehensive clinical trial information for Atopic Dermatitis through Pure Global AI's free database. This collection includes 784 clinical trials across multiple phases including N/A, Phase 2, Phase 3. Currently, 152 trials are actively recruiting participants.

Research for Atopic Dermatitis is being conducted in United States of America, China, Germany and 7+ other countries. Leading sponsors include LEO Pharma and Eli Lilly and Company. Pure Global AI offers free access to clinical trial data from ClinicalTrials.gov, WHO ICTRP, and regional registries worldwide.

Pure Global AI provides free access to 784 clinical trials studying Atopic Dermatitis, aggregated from major global registries including ClinicalTrials.gov, WHO ICTRP, and regional databases.

The trials span multiple phases, from early Phase 1 safety studies to large-scale Phase 3 efficacy trials, conducted across 10+ countries.

Top research sponsors include LEO Pharma, Eli Lilly and Company, AbbVie, among others.